Water

Water

SCHEMBL487061

O.O.O.O.[Cr+3].[F-].[F-].[F-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL845276 1.00
Water SCHEMBL10451236 1.00
Fluoride Ion SCHEMBL50564 0.82
Water SCHEMBL31001052 0.82
Water SCHEMBL23631871 0.67
Water SCHEMBL25293610 0.67
Water SCHEMBL11364888 0.67
Water SCHEMBL25293755 0.67
Water SCHEMBL38219 0.67
Water SCHEMBL7594200 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321388-A Preparation method of deuterated methanol with high conversion rate 徐州亚兴医疗科技有限公司 2021-02-05 CN claimed
US-9809515-B2 Dehydrofluorination of pentafluoroalkanes to form tetrafluoroolefins ARKEMA INC. (US) 2017-11-07 US claimed
US-20170022128-A1 DEHYDROFLUORINATION OF PENTAFLUOROALKANES TO FORM TETRAFLUOROOLEFINS ARKEMA INC (US) 2017-01-26 US claimed
US-9492816-B2 Dehydrofluorination of pentafluoroalkanes to form tetrafluoroolefins ARKEMA INC. (US) 2016-11-15 US claimed
EP-2569269-A1 DEHYDROFLUORINATION OF PENTAFLUOROALKANES TO FORM TETRAFLUOROOLEFINS ARKEMA INC. (US) 2013-03-20 EP claimed
US-20130060069-A1 DEHYDROFLUORINATION OF PENTAFLUOROALKANES TO FORM TETRAFLUOROOLEFINS ARKEMA INC. (US) 2013-03-07 US claimed
WO-2011140013-A1 DEHYDROFLUORINATION OF PENTAFLUOROALKANES TO FORM TETRAFLUOROOLEFINS ARKEMA INC. (US) 2011-11-10 WO claimed
US-7211607-B2 Method for producing high surface area chromia materials for catalysis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-05-01 US claimed
US-20030202933-A1 Method for producing high surface area chromia materials for catalysis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-10-30 US claimed
US-20260137621-A1 ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS DIASOME PHARMACEUTICALS INC (US) 2026-05-21 US disclosed
US-20260124139-A1 LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL DIASOME PHARMACEUTICALS INC (US) 2026-05-07 US disclosed
US-20250288521-A1 ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS DIASOME PHARMACEUTICALS INC (US) 2025-09-18 US disclosed
US-RE50296-E1 Electron beam resist composition THE UNIVERSITY OF MANCHESTER (GB) 2025-02-11 US disclosed
CN-119082627-A Aluminum alloy for automobile main structural beam and preparation method thereof 哈尔滨宏源铝业有限责任公司 2024-12-06 CN disclosed
EP-1087753-A1 TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM SDG, Inc. (US) 2001-04-04 EP disclosed
WO-1999059545-A9 TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM SDG INC (US) 2000-04-27 WO disclosed
EP-0747510-B1 Deposition of chromium oxides from a trivalent chromium solution ATOTECH USA INC (US) 2000-04-19 EP disclosed
US-6004448-A APPLYING A COATING OF CHROMIUM OXIDE ON A ELECTROCONDUCTIVE METAL SUBSTRATE FROM CHROMIUM BATH WITH BUFFERS ATOTECH USA, INC. (US) 1999-12-21 US disclosed
WO-1999059545-A1 TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM SDG, INC. (US) 1999-11-25 WO disclosed
EP-0747510-A1 Deposition of chromium oxides from a trivalent chromium solution ATOTECH USA, INC. (US) 1996-12-11 EP disclosed